Premium
Chemotherapeutic activity of synthetic antimicrobial peptides: correlation between chemotherapeutic activity and neutrophil‐activating activity
Author(s) -
Nakajima Yuki,
Alvarez-Bravo Juan,
Cho Jang-hyun,
Homma Ko-ichi,
Kanegasaki Shiro,
Natori Shunji
Publication year - 1997
Publication title -
febs letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.593
H-Index - 257
eISSN - 1873-3468
pISSN - 0014-5793
DOI - 10.1016/s0014-5793(97)01101-0
Subject(s) - in vitro , antimicrobial , antibacterial activity , superoxide , chemistry , pharmacology , biological activity , microbiology and biotechnology , antibiotics , enantiomer , biology , bacteria , biochemistry , stereochemistry , enzyme , genetics
The chemotherapeutic activity of three synthetic antibacterial peptides was investigated. KLKKLK‐NH 2 and its d ‐enantiomer showed significant chemotherapeutic activity in MRSA‐infected mice, whereas KLKLLLKLK‐NH 2 , which showed the highest antibacterial activity among them in vitro, was found to have almost no ability to prevent MRSA infection. These results suggest that the antibacterial activity of peptides assessed in vitro does not necessarily correlate with their chemotherapeutic activity. We found that KLKKLK‐NH 2 and its d ‐enantiomer, but not KLKLLLKLK‐NH 2 , have the ability to activate human neutrophils to produce superoxide, suggesting that the prevention of MRSA infection by these peptides is not simply due to their direct bactericidal activity but to augmentation of the systemic defense mechanism mediated by neutrophils.